13. A 26-week study of efficacy and safety of delayed-release prednisone in newly diagnosed cases of giant cell arteritis: an interim analysis.

Autor: Raine, Charles, Maw, Win, Williams, Mark, Gayford, Dawn, Mapplebeck, Sarah, Mackerness, Craig, Dasgupta, Bhaskar
Předmět:
Zdroj: Rheumatology; May2014 Supplement, Vol. 53 Issue suppl_2, pi7-i8, 1p
Abstrakt: The article presents the 26-week study which examined the effectiveness and safety of modified-release (MR) prednisone in newly diagnosed cases of giant cell arteritis (GCA) in Great Britain. It also examines the duration of the clinical response of the drug, the steroid-related complications, and the quality of life outcomes. Based on the results, MR prednisone has similar effectiveness with standard immediate release (IR) prednisone.
Databáze: Complementary Index